MedPath

德州德药制药有限公司

Ownership
-
Established
2003-12-29
Employees
-
Market Cap
-
Website
http://www.deyao.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

81

NMPA:81

Drug Approvals

Esomeprazole Sodium For Injection

Product Name
注射用艾司奥美拉唑钠
Approval Number
国药准字H20193267
Approval Date
May 11, 2024
NMPA

Fluorouracil for Injection

Product Name
注射用氟尿嘧啶
Approval Number
国药准字H20051619
Approval Date
Sep 11, 2023
NMPA

Nifedipine Controlled-release Tablets

Product Name
硝苯地平控释片
Approval Number
国药准字H20233735
Approval Date
Jun 14, 2023
NMPA

Pemetrexed Disodium for Injection

Product Name
注射用培美曲塞二钠
Approval Number
国药准字H20080230
Approval Date
Apr 3, 2023
NMPA

Pemetrexed Disodium for Injection

Product Name
注射用培美曲塞二钠
Approval Number
国药准字H20163003
Approval Date
Apr 3, 2023
NMPA

Pemetrexed Disodium for Injection

Product Name
注射用培美曲塞二钠
Approval Number
国药准字H20163004
Approval Date
Apr 3, 2023
NMPA

Thiamazole Tablets

Product Name
甲巯咪唑片
Approval Number
国药准字H37020105
Approval Date
Nov 19, 2021
NMPA

Cisplatin for Injection

Product Name
注射用顺铂
Approval Number
国药准字H20023236
Approval Date
Feb 20, 2021
NMPA

Bifendate Pills

Product Name
联苯双酯滴丸
Approval Number
国药准字H20033403
Approval Date
Feb 20, 2021
NMPA

Bifendate Pills

Product Name
联苯双酯滴丸
Approval Number
国药准字H37020113
Approval Date
Feb 20, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.